![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.298, 2001-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New Ammunition for the Pharma Industry
Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 5, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharma industry less than healthy
Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NHS reforms: consequences for the pharma industry
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 611, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Deal offered to pharma industry in Hungary
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 294, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Growth in the US, UK and Swedish pharma markets in 2002
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 401, 2003-01 ,pp. :